ABEONA THERAPEUTICS INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Abeona Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Abeona Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $109M, a 8.66% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $109M +$8.69M +8.66% Dec 31, 2023 10-K 2024-03-18
Q4 2022 $100M +$10.6M +11.8% Dec 31, 2022 10-K 2024-03-18
Q4 2021 $89.7M +$11.4M +14.5% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $78.3M +$11M +16.3% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $67.3M +$15.6M +30.2% Dec 31, 2019 10-K 2021-03-24
Q4 2018 $51.7M -$11.1M -17.7% Dec 31, 2018 10-K 2020-03-16
Q4 2017 $62.8M -$25.2M -28.6% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $88M +$8.52M +10.7% Dec 31, 2016 10-K 2018-03-16
Q4 2015 $79.5M +$5.2M +7% Dec 31, 2015 10-K 2017-03-30
Q4 2014 $74.3M +$3.44M +4.86% Dec 31, 2014 10-K 2016-03-30
Q4 2013 $70.9M -$6.31M -8.17% Dec 31, 2013 10-K 2015-03-31
Q4 2012 $77.2M +$2.13M +2.84% Dec 31, 2012 10-K 2014-03-26
Q4 2011 $75M Dec 31, 2011 10-K 2013-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.